当前位置：
X-MOL 学术
›
Curr. Med. Res. Opin.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Effectiveness and safety of anticoagulants among patients with venous thromboembolism and active cancer who also had prior bleed or prior renal disease
Current Medical Research and Opinion ( IF 2.3 ) Pub Date : 2024-02-13 , DOI: 10.1080/03007995.2024.2313092 Alexander T. Cohen 1 , Virginia Noxon 2 , Amol D Dhamane 3 , Shrushti Shah 2 , Dionne M. Hines 4 , Tamuno Alfred 4 , José Chaves 5 , Xuemei Luo 6
Current Medical Research and Opinion ( IF 2.3 ) Pub Date : 2024-02-13 , DOI: 10.1080/03007995.2024.2313092 Alexander T. Cohen 1 , Virginia Noxon 2 , Amol D Dhamane 3 , Shrushti Shah 2 , Dionne M. Hines 4 , Tamuno Alfred 4 , José Chaves 5 , Xuemei Luo 6
Affiliation
Patients with active cancer and venous thromboembolism (VTE) have elevated risk of recurrent VTE (rVTE) and major bleeding (MB). The risk is even higher within those with a prior bleeding event or ...
中文翻译：
抗凝剂对患有静脉血栓栓塞和活动性癌症且既往有出血或既往有肾脏疾病的患者的有效性和安全性
患有活动性癌症和静脉血栓栓塞 (VTE) 的患者复发 VTE (rVTE) 和大出血 (MB) 的风险较高。对于那些既往有出血事件或...的人来说，风险甚至更高。
更新日期：2024-02-13
中文翻译：
抗凝剂对患有静脉血栓栓塞和活动性癌症且既往有出血或既往有肾脏疾病的患者的有效性和安全性
患有活动性癌症和静脉血栓栓塞 (VTE) 的患者复发 VTE (rVTE) 和大出血 (MB) 的风险较高。对于那些既往有出血事件或...的人来说，风险甚至更高。
京公网安备 11010802027423号